Pamela Garzone

Pamela Garzone

Director/Board Member at CUE BIOPHARMA, INC.

Net worth: 482 328 $ as of 31/08/2026

72 year
Health Technology
Consumer Services

Profile

Dr. Pamela D.
Garzone
is an Independent Director at Cue Biopharma, Inc. and a Chief Development Officer at Anixa Biosciences, Inc. She is on the Board of Directors at Cue Biopharma, Inc., Centivax, Inc. and Temple Therapeutics, Inc. Dr. Garzone was previously employed as a Chief Medical Officer-Calibr by The Scripps Research Institute, a Vice President-Group Asset Team Lead by Pfizer Inc., and an Assistant Professor by University of Pittsburgh.
She received her undergraduate degree from Purdue University, a graduate degree from the University of Pittsburgh and a doctorate degree from the University of Pittsburgh.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
09/07/2026 18,900 ( 0.26% ) 482 328 $ 31/08/2026

Pamela Garzone active positions

CompaniesPositionStart
ANIXA BIOSCIENCES, INC. Corporate Officer/Principal 07/09/2021
CUE BIOPHARMA, INC. Director/Board Member 19/04/2023
Director/Board Member 01/09/2022
Temple Therapeutics Inc
Director/Board Member -

Former positions of Pamela Garzone

CompaniesPositionEnd
Corporate Officer/Principal 01/05/2021
PFIZER INC. Corporate Officer/Principal 01/05/2019
Corporate Officer/Principal -
See the detail of Pamela Garzone's experience

Training of Pamela Garzone

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

96

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Temple Therapeutics Inc

  1. Stock Market
  2. Insiders
  3. Pamela Garzone